Scaling Biotech
Jesse JohnsonExploring how processes within drug discovery are changing to take advantage of new models and technology.
| Platform |  | Pricing | Only free issues | Publishes | Weekly |
|---|---|---|---|---|---|
| Issues | 288 | Founded | 6 years ago | Last Issue | 4 days ago |
| Active | |||||
Read this Newsletter
scalingbiotech.substack.comLatest Issues
Foundation models can’t compete on cost
One idea I’ve touched on a few times, but I think deserves a deeper dive, is the tradeoff between cost and accuracy of digital models, and how this impacts the role bio foundation models will play in drug discovery. (This applies to most of...
Drug discovery is built around lousy data
I’ve been exploring how the relationship between the newest generation of digital models and the drug discovery process is different compared to older models. One difference I’ve touched on, but haven’t explored deeply yet, is how they appr...
Internal vs External development: ELNs vs BFX platforms
The last few weeks, I’ve been exploring the differences between older categories of digital tools for drug discovery that came out of internal projects at pharma companies vs newer categories that were mostly introduced as commercial produc...
Forget AI scientists. Focus on removing technical friction
In the last few posts, I’ve been writing about ways that the most recent wave of digital technology for drug discovery is fundamentally different from previous waves. In particular, the new tech requires fundamental changes to the drug disc...
Automation adoption wasn’t defined by automation
In the last few posts I've been arguing that newer digital tools don't fit as cleanly into existing drug discovery processes as past waves of technology, and that the most effective ways to adopt these new tools will require fundamentally c...
Key Facts
Audience Metrics
Subscribers, engagement, traffic and sponsorship for Scaling Biotech.
| Subscribers | Engagement | 68 | Monthly Web Visits | ||
|---|---|---|---|---|---|
| Accepts Sponsors | Estimated Cost per Ad | ||||
Explore More
Authors
The writers behind this newsletter.
Founder of Merelogic
Social
Frequently Asked Questions
How can I access the email archive for Scaling Biotech?
You can find recent issues that have been published by Scaling Biotech on Reletter by scrolling up to where it says Latest Issues. Tap on the link for any of the most recent emails or hit More Issues to see older ones.
How many subscribers does Scaling Biotech have?
To see how many people subscribe to Scaling Biotech, simply upgrade your Reletter account. We provide readership numbers and lots of other stats for this newsletter so you can decide if it's worth reaching out to.
How can I advertise in Scaling Biotech?
Newsletter advertising can be extremely effective when it's done right. Before you pitch Scaling Biotech as a potential sponsor or partner, make sure that you've done your research and checked its newsletter stats with Reletter.
Then, personalize one of our winning pitching templates and send it to the right person using the contact info provided.
How much does it cost to sponsor a publication like Scaling Biotech?
Newsletter ad rates (or CPM) vary depending on many factors, including industry, number of subscribers, open rate, ad placement and more.
To find out how much an ad will cost, contact Scaling Biotech using the contact information provided and ask for a copy of their media kit.
How can I find newsletters related to Scaling Biotech?
Scroll up to where it says Related Newsletters to see other publications like Scaling Biotech. You can also search our email newsletter directory to discover other newsletters that cover the topics you're interested in.
How do I contact Scaling Biotech?
Reletter provides this newsletter's website URL above, where you will often find their contact information. We also provide links to associated social media accounts and pitching templates so you can reach out fast.